Humanigen is not currently accepting enquiries regarding lenzilumab™™ for emergency use.

Humanigen's Phase III study in COVID-19 is now enrolling. Click here for more information.

See also:

Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients (more information)

Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients (more information)

  • Twitter

©2020 Humanigen, Inc.  All rights reserved